Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About AbCellera

AbCellera (NASDAQ: ABCL) provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of monoclonal antibody therapies. Its single-cell platform integrates end-to-end capabilities for therapeutic antibody discovery through a combination of technologies including proprietary immunizations, microfluidics, high-throughput imaging, genomics, computation, and laboratory automation.

AbCellera Headquarter Location

2215 Yukon Street

Vancouver, British Columbia, V5Y 0A1,



Latest AbCellera News

AbCellera eyes hiring relocation specialist to gain edge in global talent fight

Oct 22, 2021

AbCellera eyes hiring relocation specialist to gain edge in global talent fight Last updated 1 hour ago This is part five of The Logic’s in-depth series exploring how Canada is faring in the global competition for tech talent, as economies reopen and companies and governments jockey for advantage in a remote-work world. VANCOUVER — As AbCellera looks to add hundreds of staff to its growing Vancouver headquarters, it must tap into a global candidate pool to fill some highly specialized positions in a heated tech-talent market. Join now to start reading premium, award-winning journalism. By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing AbCellera

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned AbCellera in 5 CB Insights research briefs, most recently on Sep 28, 2020.

Expert Collections containing AbCellera

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AbCellera is included in 6 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.


Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.


Artificial Intelligence

7,895 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Infectious Disease

2,225 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.


Digital Health 150 (2020)

150 items

The winners of the second annual CB Insights Digital Health 150.


Digital Health

11,260 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

AbCellera Patents

AbCellera has filed 1 patent.

The 3 most popular patent topics include:

  • Betacoronaviruses
  • COVID-19
  • Chronic fatigue syndrome
patents chart

Application Date

Grant Date


Related Topics



Betacoronaviruses, Coronaviridae, COVID-19, Viral respiratory tract infections, Chronic fatigue syndrome


Application Date


Grant Date


Related Topics

Betacoronaviruses, Coronaviridae, COVID-19, Viral respiratory tract infections, Chronic fatigue syndrome



AbCellera Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AbCellera Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.